Work

Keynote 290: Pembrolizumab (pem) in combination with stereotactic body radiotherapy for resectable liver metastatic colorectal cancer.

Year: 2018

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2018.36.4_suppl.tps874

Authors: Dustin A. Deming, David H. Kim, Kristina Matkowskyj, Nataliya Volodymyrivna Uboha, Sam Joseph Lubner, Noelle K. LoConte, Daniel Mulkerin, Daniel Abbott, Sharon M. Weber, Emily Winslow, Robert Jeraj, Mark A. Ritter, Scott Perlman, Jens C. Eickhoff, Michael Frederick Bassetti

Institutions: University of Wisconsin–Madison, University of Wisconsin Carbone Cancer Center

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2907101256

Cites:

Cited by:

Related to: 10